SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is generating intense community debate as investors scrutinize the company's ability to secure significant defense contracts and transition from prototype testing to commercial revenue. Sentiment remains deeply divided, with some bulls pointing to progress in government drone programs and industry partnerships as long-term catalysts, while critics express frustration over persistent share dilution, management leadership, and a lack of verified sales.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is seeing intense social media activity as the community reacts to high-profile political developments, including the death of Senator Lindsey Graham and ongoing speculation regarding the health and status of other political figures. Conversations are heavily polarized, with users clashing over allegations of government corruption, the impact of the Iran conflict on energy markets, and broader debates surrounding the administration's policies.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is experiencing high volatility and significant trading volume as investors react to the company's sale of its Phase 2 complement inhibitor program to Akebia Therapeutics for up to $592 million. The community is actively debating the stock's potential for a short squeeze versus the risks of dilution and potential profit-taking, with many participants closely monitoring key support levels and price action to gauge if the momentum can sustain.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending as investors debate whether the recent price movement signals a genuine breakout or another typical pump-and-dump cycle before earnings. Community sentiment is deeply divided between long-term holders focusing on business growth and fintech potential versus traders who are actively betting against the stock through short positions and puts.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing significant volatility driven by the upcoming SK Hynix U.S. IPO and major institutional rebalancing by the Korean National Pension Service. While investors are debating whether the recent price swings represent a buying opportunity or a risky falling knife, community sentiment remains sharply divided over the impact of the pending 20-for-1 stock split and the broader memory sector's performance.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as record-breaking monthly revenue growth confirms sustained demand for AI infrastructure, keeping the company at the critical bottleneck of the global semiconductor supply chain. Investors are actively debating the stock's resilience against geopolitical headwinds and potential chip curbs, while monitoring upcoming earnings to see if manufacturing capacity can keep pace with accelerating AI chip requirements.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently garnering significant attention from investors and the broader crypto community due to its notable relative strength against major assets and its expanding role in the tokenization of real-world assets. Market participants are actively discussing price action, staking strategies, and the potential for a larger breakout, while debates continue regarding its long-term utility versus legacy cryptocurrencies.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as it hits all-time highs, driven by excitement over potential on-device AI advancements through PrismML and renewed momentum in its semiconductor supply chain strategies. Community discussion is heavily split between bullish traders riding the momentum toward new records and bearish market participants concerned about valuation sustainability and aggressive legal action taken against OpenAI.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. ($PURR) is trending as investors debate its potential for a gamma squeeze and institutional rotation, fueled by its role as a public market proxy for the rapidly growing HYPE crypto ecosystem. While some community members highlight its inclusion in the Russell index and recent institutional accumulation as strong catalysts for future growth, others are expressing caution regarding short-term price volatility and potential disconnects between the stock and its underlying token.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending following the board's authorization of a $50 million share repurchase program, a move the community views as a signal of financial strength alongside debt redemption efforts. Investors are actively debating the stock's long-term potential, with bullish sentiment focusing on disciplined capital allocation while some voices express skepticism regarding broader management execution and valuation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assembly Biosciences (ASMB) Reports Q1 Loss, Misses Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +26.03% and -10.73%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Assembly Biosciences' (ASMB) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued a "buy" rating and issued a $50.00 price objective on shares of Assembly Biosciences in a research note on Monday...

Assembly Biosciences (ASMB) Projected to Post Quarterly Earnings on Thursday

Assembly Biosciences (NASDAQ:ASMB) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-assembly-biosciences-inc-stock...

Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat...

Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim

Guggenheim raised their price objective on shares of Assembly Biosciences from $39.00 to $43.00 and gave the company a "buy" rating in a research note on Monday...

HC Wainwright Analysts Lower Earnings Estimates for ASMB

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share (EPS) estimates for Assembly Biosciences in a report released on Thursday, March...

Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy

Wall Street Zen upgraded shares of Assembly Biosciences from a "buy" rating to a "strong-buy" rating in a research report on Sunday...

Q1 Earnings Estimate for ASMB Issued By HC Wainwright

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings estimates for Assembly Biosciences in a report issued on Thursday, March 26th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.16) per share for...

Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $50.00 price objective on shares of Assembly Biosciences in a research report on Thursday...

Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Assembly Biosciences from a "hold" rating to a "buy" rating in a research report on Saturday...

Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.

Assembly Biosciences Inc

Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs

Equity

Bullish Sentiment

Yes, significantly

Yes, moderately

No change

Decrease

Do you plan to increase your ETF investments over the next 12 months? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Do you plan to increase your ETF investments over the next 12 months? 
 
*Sponsored by Calamos and S&P Global

Current Price	$27.20
Prev Close	$27.40
Open	$26.61
Dividend Yield	0.00%
50-Day Moving Average	$26.78
Beta	1.10
Avg. Volume	282,063.60
PE Ratio	-22.82

52-Week High	$39.71
52-Week Low	$16.90
Market Capitalization	$542.99M
EPS (Annual)	-$0.5461
Price to Book	2.19
Revenue Per Employee	$990,452.06

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASMBAssembly Biosciences Inc

Latest ASMB News